Diagnosis, Clinical Manifestations and Treatment of Lyme Disease
DOI:
https://doi.org/10.12775/QS.2024.18.53283Keywords
Lyme borreliosis, Lyme disease, Lyme disease diagnosis, Lyme disease clinical manifestations, Lyme disease treatmentAbstract
Introduction and purpose
Lyme disease was identified in the 1970s. It is an anthropozoonosis caused by spirochetes from the Borrelia family. This disease is the most common one caused by pathogens transmitted by ticks. It can manifest in various ways and typically progresses through three phases, each of which can present characteristic symptoms of infection. However, it often progresses asymptomatically. Antibiotics are widely used in the treatment of various forms of Lyme disease and demonstrate satisfactory efficacy. However, the most important aspect is the prevention of infections through personal protection against exposure. The aim of the article is to summarize information on Lyme disease, its risk factors, diagnosis, clinical manifestations, and treatment.
Materials and methods
The literature available in the PubMed database is searched using terms such as Lyme borreliosis and Lyme disease.
Results
Lyme disease is a moderately understood condition. Its risk factors have been studied, allowing us to identify those particularly at risk. However, despite this, the condition often presents diagnostic challenges, requiring considerable experience from clinicians. The disease can manifest in various ways, and antibiotics are an effective therapy in most cases. Despite numerous scientific studies on Lyme disease, not all pathophysiological mechanisms have been elucidated. Additionally, there is an ongoing debate regarding the validity of post-treatment Lyme disease syndrome (PTLDS).
Conclusions
Research on Lyme disease continues to provide new information, from diagnostics and clinical manifestations to treatment. Knowledge about infections caused by genospecies of the Borrelia family is extensive. However, there are still areas that are less well understood.
References
References:
Magnavita N, Capitanelli I, Olesanmi O, Chirico F. Occupational Lyme Disease: A Systematic Review and Meta-Analysis. 2022 Feb;12(2): 296. doi: 10.3390/diagnostics12020296. PMID: 35204387; PMCID: PMC8870942.
Lindström BE, Skogman BH, Lindström AK, Tallstedt L, Nilsson K. Borrelia Ocular Infection: A Case Report and a Systematic Review of Published Cases. 2022 Jan;65(2): 121–130. doi: 10.1159/000521307. PMID: 35034015.
Krasińska-Mazur M, Homel P, Gala A, Stradomska J, Pihut M. Differential diagnosis of temporomandibular disorders - a review of the literature. 2022;62(2):121-137. doi: 10.24425/fmc.2022.141703. PMID:36256899.
Burn L , Pilz A, Vyse A, Gutiérrez Rabá AV, Angulo FJ, Tran TMP, et al. Seroprevalence of Lyme Borreliosis in Europe: Results from a Systematic Literature Review (2005-2020). 2023 Apr;23(4):195-220. doi: 10.1089/vbz.2022.0069. PMID: 37071401; PMCID: PMC10122246.
Fischhoff IR, Keesing F, Ostfeld RS. Risk Factors for Bites and Diseases Associated With Black-Legged Ticks: A Meta-Analysis. 2019 Sep 1;188(9):1742-1750. doi: 10.1093/aje/kwz130. PMID: 31145773; PMCID: PMC6736203.
Shafquat M, Angulo FJ, Pilz A, Moïsi JC, Stark JH. The Incidence of Lyme Borreliosis Among Children. 2023 Oct 1;42(10):867-874. doi: 10.1097/INF.0000000000004040. PMID: 37406218; PMCID: PMC10501351.
Burn L, Vyse A, Pilz A, Tran TMP, Fletcher MA, Angulo FJ, et al. Incidence of Lyme Borreliosis in Europe: A Systematic Review (2005–2020). 2023 Apr;23(4):172-194. doi: 10.1089/vbz.2022.0070. PMID: 37071407; PMCID: PMC10122234.
Branda JA, Steere AC. Laboratory Diagnosis of Lyme Borreliosis. 2021 Jan 27;34(2):e00018-19. doi: 10.1128/CMR.00018-19. PMID: 33504503; PMCID: PMC7849240.
Jarosz AC, Badawi A. Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution. 2019 Jan;68(1):7-17. doi: 10.1007/s00011-018-1180-5. Epub 2018 Aug 18. PMID: 30121835; PMCID: PMC6314976.
Fischhoff IR, Bowden SE, Keesing F, Ostfeld RS. Systematic review and meta-analysis of tick-borne disease risk factors in residential yards, neighborhoods, and beyond. 2019 Oct 17;19(1):861. doi: 10.1186/s12879-019-4484-3. PMID: 31623574; PMCID: PMC6798452.
Leeflang MMG, Ang CW, Berkhout J, Bijlmer HA, Bortel W, Brandenburg AH et al. The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis. 2016 Mar 25:16:140. doi: 10.1186/s12879-016-1468-4. PMID: 27013465; PMCID: PMC4807538.
Sébastien P, Jacques D, Catherine P, Xavier G. Diagnosis and treatment of “chronic Lyme”: primum non nocere. 2023 Oct 2;23(1):642. doi: 10.1186/s12879-023-08618-w. PMID: 37784031; PMCID: PMC10544220.
Steere AC, Strle F, Wormser GP, Hu LT, Branda JA, Hovius JWR, et al. Lyme borreliosis. 2016 Dec 15:2:16090. doi: 10.1038/nrdp.2016.90. PMID: 27976670; PMCID: PMC5539539.
Knudtzen FC, Jensen TG, Andersen NS, Johansen IS, Hovius JW, Skarphédinsson S. An intervention in general practice to improve the management of Lyme borreliosis in Denmark. 2022 Jun 1;32(3):436-442. doi: 10.1093/eurpub/ckac013. PMID: 35323885; PMCID: PMC9159330.
Stupica D, Bajrović FF, Blagus R, Kišek TC, Collinet-Adler S, Ružić-Sabljić E, et al. Association between statin use and clinical course, microbiologic characteristics, and long-term outcome of early Lyme borreliosis. A post hoc analysis of prospective clinical trials of adult patients with erythema migrans. 2021 Dec 16;16(12):e0261194. doi: 10.1371/journal.pone.0261194. PMID: 34914751; PMCID: PMC8675750.
Eliassen KE, Reiso H, Berild D, Lindbæk M. Comparison of phenoxymethylpenicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a 1-year follow-up. 2018 Dec;24(12):1290-1296. doi: 10.1016/j.cmi.2018.02.028. PMID: 29505880.
Geebelen L, Van Cauteren D, Devleesschauwer B, Moreels S, Tersago K, Van Oyen H, et al. Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015-2017. 2019 Apr;10(3):598-605. doi: 10.1016/j.ttbdis.2018.12.007. PMID: 30772196.
Moter SE, Hofmann H, Wallich R, Simon MM, Kramer MD. Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR. 1994 Dec;32(12):2980-8. doi: 10.1128/jcm.32.12.2980-2988.1994. PMID: 7883886; PMCID: PMC264211.
Gade A, Matin T, Rubenstein R, Robinson CA. Acrodermatitis Chronica Atrophicans. 2023 Jan 2. PMID: 33085436.
Moniuszko-Malinowska A , Czupryna P, Dunaj J, Pancewicz S, Garkowski A, Kondrusik M, et al. Acrodermatitis chronica atrophicans: various faces of the late form of Lyme borreliosis. 2018 Oct;35(5):490-494. doi: 10.5114/ada.2018.77240. Epub 2018 Jul 19. PMID: 30429707; PMCID: PMC6232541.
Knudtzen FC, Eikeland R, Bremell D, Quist-Paulsen E, Johansen IS, Solheim AM, et al. Lyme neuroborreliosis with encephalitis; a systematic literature review and a Scandinavian cohort study. 2022 May;28(5):649-656. doi: 10.1016/j.cmi.2021.11.001. PMID: 34768019.
Marques A, Okpali G, Liepshutz K, Ortega-Villa AM. Characteristics and outcome of facial nerve palsy from Lyme neuroborreliosis in the United States. 2022 Jan;9(1):41-49. doi: 10.1002/acn3.51488. PMID: 35064770; PMCID: PMC8791801.
Ogrinc K, Kastrin A, Lotrič-Furlan S, Bogovič P, Rojko T, Maraspin V, et al. Colocalization of Radicular Pain and Erythema Migrans in Patients With Bannwarth Syndrome Suggests a Direct Spread of Borrelia Into the Central Nervous System. 2022 Aug 24;75(1):81-87. doi: 10.1093/cid/ciab867. PMID: 34606609; PMCID: PMC9402604.
Rauer S, Kastenbauer S, Fingerle V, Hunfeld KP, Huppertz HI, Dersch R. Lyme Neuroborreliosis. 2018 Nov 9;115(45):751-756. doi: 10.3238/arztebl.2018.0751. PMID: 30573008; PMCID: PMC6323132.
Garkowski A, Zajkowska J, Zajkowska A, Kułakowska A, Zajkowska O, Kubas B, et al. Cerebrovascular Manifestations of Lyme Neuroborreliosis-A Systematic Review of Published Cases. 2017 Apr 20:8:146. doi: 10.3389/fneur.2017.00146. PMID: 28473801; PMCID: PMC5397664.
Lu Y, Zand R. Characteristics of Lyme optic neuritis: a case report of Lyme associated bilateral optic neuritis and systematic review of the literature. 2022 Mar 23;22(1):113. doi: 10.1186/s12883-022-02627-z. PMID: 35321665; PMCID: PMC8941763.
Besant G, Wan D, Yeung C, Blakely C, Branscombe P, Suarez-Fuster L, et al. Suspicious index in Lyme carditis: Systematic review and proposed new risk score. 2018 Dec;41(12):1611-1616. doi: 10.1002/clc.23102. Epub 2018 Nov 26. PMID: 30350436; PMCID: PMC6489885.
Radesich C, Del Mestre E, Medo K, Vitrella G, Manca P, Chiatto M, et al. Lyme Carditis: From Pathophysiology to Clinical Management. 2022 May 15;11(5):582. doi: 10.3390/pathogens11050582. PMID: 35631104; PMCID: PMC9145515.
Arvikar SL, Steere AC. Lyme Arthritis. 2022 Sep;36(3):563-577. doi: 10.1016/j.idc.2022.03.006. PMID: 36116835; PMCID: PMC9533683.
Badawi A, Arora P, Brenner D. Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review. 2019 Mar;8(1):5-22. doi: 10.1007/s40121-018-0223-0. Epub 2018 Nov 30. PMID: 30506261; PMCID: PMC6374232.
Cruz Jr AI, Anari JB, Ramirez JM, Sankar WN, Baldwin KD. Distinguishing Pediatric Lyme Arthritis of the Hip from Transient Synovitis and Acute Bacterial Septic Arthritis: A Systematic Review and Meta-analysis. 2018 Jan 25;10(1):e2112. doi: 10.7759/cureus.2112. PMID: 29581924; PMCID: PMC5866113.
Lochhead RB, Strle K, Arvikar SL, Weis JJ, Steere AC. Lyme arthritis: linking infection, inflammation and autoimmunity. 2021 August ; 17(8): 449–461. doi:10.1038/s41584-021-00648-5. PMID: 34226730; PMCID: PMC9488587.
Bai NA, Richardson CS. Posttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesis. 2023 Jun 11;9(3):183-190. doi: 10.1002/cdt3.74. eCollection 2023 Sep. PMID: 37711861; PMCID: PMC10497844.
Lantos PM, Wormser GP. Chronic coinfections in patients diagnosed with chronic Lyme disease: a systematic literature review. 2014 Nov;127(11):1105-1110. doi: 10.1016/j.amjmed.2014.05.036. Epub 2014 Jun 12. PMID: 24929022; PMCID: PMC4252587.
Yang J, Wen A, Kong J, Yue P, Cao W, Xu X, et al. Forty Years of Evidence on the Efficacy and Safety of Oral and Injectable Antibiotics for Treating Lyme Disease of Adults and Children: A Network Meta-Analysis. 2021 Dec 22;9(3):e0076121. doi: 10.1128/Spectrum.00761-21. Epub 2021 Nov 10. PMID: 34756070; PMCID: PMC8579938.
Omotosho TB, Sherchan R, Ying GW, Shayuk M. A Unique Case of Bannwarth Syndrome in Early Disseminated Lyme Disease. 2021 Apr 25;13(4):e14680. doi: 10.7759/cureus.14680. PMID: 33912367; PMCID: PMC8071476.
Zhang X, Jiang Y, Chen Y, Yang J, Zhang X, Xing L, et al. Efficacy and safety of antibiotic therapy for post-Lyme disease? A systematic review and network meta-analysis. 2023 Jan 12;23(1):22. doi: 10.1186/s12879-023-07989-4. PMID: 36635681; PMCID: PMC9838005.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Katarzyna Jakubowska, Aleksandra Janocha, Aneta Jerzak, Paweł Ziemba

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 219
Number of citations: 0